# A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure

> **NCT00422461** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 135 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** placebo
- **DRUG:** PF-00489791
- **DRUG:** PF-00489791
- **DRUG:** PF-00489791

## Key facts

- **NCT ID:** NCT00422461
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02-27
- **Primary completion:** 2008-01-28
- **Final completion:** 2008-01-28
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2021-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00422461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00422461, "A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00422461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*